Now Playing
Emergent's 13-Month Unicorn, Chai's $400M & Production AI Funding
Audio is available on Spreaker — see link below.
Five funding rounds reveal where enterprise AI capital is actually landing this week — from Emergent's 13-month unicorn sprint to Chai Discovery's $3.8B pharma bet. Direct analysis of who's winning, what the valuations assume, and where the real risk sits.
Audio is available on Spreaker — see link below.
Emergent just hit a one-point-five billion dollar valuation. That's a five-times jump in six months.
Shifting to a very different kind of long-term bet. Chai Discovery closed four hundred million dollars in funding led by Index Ventures at a three-point-eight billion dollar valuation.
Two other rounds this week point to a clearer, more immediate signal. Spectro Cloud raised over one hundred million dollars from Goldman Sachs Growth Equity to move AI infrastructure into production environments.
At cancer care unicorn Thyme Care, founder Robin Shah is stepping down as CEO effective September first. COO Brad Diephuis assumes the role.
London-based Risk Ledger closed twenty-four million pounds in a Series B led by Axiom Equity. The company targets supply chain cyber risk and is now moving aggressively into the US market.
Three things to track from here. Whether Emergent's churn data holds up as its Series C capital deploys.
Chapter summary auto-generated from the verified script. Listen to the full episode for the complete content.